SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-20-000003
Filing Date
2020-01-09
Accepted
2020-01-09 07:36:44
Documents
16
Period of Report
2020-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2019revenue8-k.htm   iXBRL 8-K 44879
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 25051
8 PACIRA BIOSCIENCES LOGO pacirabiosciencesa06.jpg GRAPHIC 27796
  Complete submission text file 0001396814-20-000003.txt   257563

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20200109.xsd EX-101.SCH 4576
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20200109_cal.xml EX-101.CAL 616
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20200109_def.xml EX-101.DEF 1466
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20200109_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20200109_pre.xml EX-101.PRE 13572
10 EXTRACTED XBRL INSTANCE DOCUMENT a2019revenue8-k_htm.xml XML 4318
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 20517031
SIC: 2834 Pharmaceutical Preparations